Beta interferon and multiple sclerosis: why the fuss?
作者信息
Mumford C J
出版信息
QJM. 1996 Jan;89(1):1-3. doi: 10.1093/oxfordjournals.qjmed.a030132.
Abstract
摘要
相似文献
1
Beta interferon and multiple sclerosis: why the fuss?
QJM. 1996 Jan;89(1):1-3. doi: 10.1093/oxfordjournals.qjmed.a030132.
2
[Interferon-beta in multiple sclerosis--who is going to be treated?].
Tidsskr Nor Laegeforen. 1999 Sep 10;119(21):3114.
3
Interferon beta in multiple sclerosis.多发性硬化症中的β干扰素。
BMJ. 1996 Nov 9;313(7066):1159. doi: 10.1136/bmj.313.7066.1159.
4
Funding of drug treatment of multiple sclerosis should not be delayed.多发性硬化症药物治疗的资金不应延迟。
BMJ. 1997 Nov 1;315(7116):1160-1. doi: 10.1136/bmj.315.7116.1160b.
5
Cost utility of drugs for multiple sclerosis. Systematic review places study in contrast.用于治疗多发性硬化症药物的成本效用。系统评价将该研究置于对比之中。
BMJ. 2000 May 27;320(7247):1474-5; author reply 1475-6.
6
Rebif offers another option for treating multiple sclerosis.利比为治疗多发性硬化症提供了另一种选择。
J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6):889-91. doi: 10.1331/108658002762063772.
7
A cost-utility analysis of interferon beta for multiple sclerosis.
Health Technol Assess. 1998;2(4):iii-54.
8
The significance of neutralizing antibodies in patients with multiple sclerosis treated with interferon beta.干扰素β治疗的多发性硬化症患者中中和抗体的意义。
Arch Neurol. 2001 Aug;58(8):1297-8. doi: 10.1001/archneur.58.8.1297.
9
[A short history of beta-interferon therapy of multiple sclerosis].[多发性硬化症β-干扰素治疗简史]
Med Klin (Munich). 2001 Sep 15;96 Suppl 1:3-9.
10
Access denied. While the decision over beta-interferon prescribing hangs in the balance, one thing's for certain--nurses will be left to pick up the pieces.访问被拒绝。虽然关于β-干扰素处方的决定悬而未决，但有一件事是肯定的——护士将不得不收拾残局。
Nurs Stand. 2000;14(44):20. doi: 10.7748/ns.14.44.20.s40.
Zotero 插件